Access to artemisinin-based combination therapy (ACT) and quinine in malaria holoendemic regions of western Kenya

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Watsierah, Carren A ^a   Ouma, Collins ^a  

^a MASENO UNIVERSITY   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; QUININE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DRUG COMBINATION; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ARTICLE; CROSS-SECTIONAL STUDY; DRUG COST; GOVERNMENT REGULATION; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HUMAN; KENYA; MAJOR CLINICAL STUDY; MALARIA; PUBLIC HOSPITAL; SOCIAL STATUS; ADULT; CHILD; DRUG COMBINATION; HEALTH CARE DELIVERY; STATISTICS AND NUMERICAL DATA;

ADULT; ANTIMALARIALS; ARTEMISININS; CHILD; CROSS-SECTIONAL STUDIES; DRUG COMBINATIONS; ETHANOLAMINES; FLUORENES; HEALTH SERVICES ACCESSIBILITY; HUMANS; KENYA; MALARIA; QUININE;

EID: 84904780091     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-290     Document Type: Article

References (32)

1. The burden of malaria mortality among African children in the year 2000. Rowe AK, Rowe SY, Snow RW, Korenromp EL, Schellenberg JR, Stein C, Nahlen BL, Bryce J, Black RE, Steketee RW, Int J Epidemiol 2006 35 691 704
2. A threshold analysis of the cost-effectiveness of artemisinin-based combination therapies in sub-saharan Africa. Coleman PG, Morel C, Shillcutt S, Goodman C, Mills AJ, Am J Trop Med Hyg 2004 71 196 204
3. MoH, National Malaria Treatment Guidelines Nairobi Kenya: Ministry of Health, Kenya 2006
4. WHO, Access to anti-malarial medicines: Improving affordability and financing of Artemisinin-Based Combination Therapy. Pan African Health Organization Geneva: WHO 2010 Malaria Control Department & Essential Drugs and Medicines Policy Department. WHO/CDS/MAL/2003.1095
5. WHO, The Use of Anti-Malarials Report of WHO informal consultations. 2000
6. The process of changing national malaria treatment policy: lessons from country-level studies. Williams HA, Durrheim D, Shretta R, Health Policy Plan 2004 19 356 370
7. WHO, On Behalf of Special Programme for Research and Training in Tropical Diseases: Partnerships for Malaria Control: Engaging Formal and Informal Private Sectors Geneva: World Health Organization 2006
8. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R, Lancet 2009 373 240 249
9. Concentration and drug prices in the retail market for malaria treatment in rural Tanzania. Goodman C, Kachur SP, Abdulla S, Bloland P, Mills A, Health Econ 2009 18 727 742
10. Effect of the Affordable Medicines Facility-malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data. Tougher S, Ye Y, Amuasi JH, Kourgueni IA, Thomson R, Goodman C, Mann AG, Ren R, Willey BA, Adegoke CA, Amin A, Ansong D, Bruxvoort K, Diallo DA, Diap G, Festo C, Johanes B, Juma E, Kalolella A, Malam O, Mberu B, Ndiaye S, Nguah SB, Seydou M, Taylor M, Rueda ST, Wamukoya M, Arnold F, Hanson K, Lancet 2012 380 1916 1926
11. DOMC, Ministry of Health (MoH), Kenya malaria worksheet 2011 http://www.kemri.org 2011, 25th Feb. 2011 at 1620 hours
12. The challenges of changing national malaria drug policy to artemisinin-based combination in Kenya. Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale W, Snow RW, Malar J 2007 6 72
13. MoPHS, Kenya Malaria Monitoring and Evaluation Plan-2009-2017 Nairobi, Kenya: Ministry of Public Health and Sanitation, Division of Malaria Control 2009
14. MoPHS, National Guidelines for Diagnosis, Treatment and Prevention of Malaria for Health Workers Nairobi, Kenya: Ministry of Public Health and Sanitation, Division of Malaria Control 2010
15. KNBS, Kenya Demographic and Health Survey 2008-09. Kenya National Bureau of Statistics (KNBS) and ICF Macro., 2010 Calverton, Maryland: KNBS and ICF Macro 2010
16. Factors determining anti-malarial drug use in a peri-urban population from malaria holoendemic region of western Kenya. Watsierah CA, Jura WG, Oyugi H, Abong'o B, Ouma C, Malar J 2010 9 295
17. Malaria drug shortages in Kenya: a major failure to provide access to effective treatment. Kangwana BB, Njogu J, Wasunna B, Kedenge SV, Memusi DN, Goodman CA, Zurovac D, Snow RW, Am J Trop Med Hyg 2009 80 737 738
18. Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: implications for private medicine retailer interventions. Abuya TO, Mutemi W, Karisa B, Ochola SA, Fegan G, Marsh V, Malar J 2007 6 57
19. Knowledge and behaviour as determinants of anti-malarial drug use in a peri-urban population from malaria holoendemic region of western Kenya. Watsierah CA, Jura WG, Raballah E, Kaseje D, Abong'o B, Ouma C, Malar J 2011 10 99
20. Reducing user fees for primary health care in Kenya: policy on paper or policy in practice? Chuma J, Musimbi J, Okungu V, Goodman C, Molyneux C, Int J Equity Health 2009 8 15
21. Kenya Malaria Fact Sheet: Malaria in Kenya at a Glance. 1600 HRS, http://www.kemri.org
22. Battling malaria in Africa. IRIN, 2009 http://www.irinnews.org/in-depth/62941/10/africa-links-references-of-publications-declarations-and-organisations: (Last accessed 22/07/2014)
23. DOMC, Kenya Malaria Programme Perfomance Review 2009 Nairobi, Kenya: Ministry of Public Health and Sanitation, Division of Malaria Control 2009
24. List of Public Health Facilities in Kenya. 2011 http://www.ehealth.or.ke/facilities-3/5/2011
25. WHO, Measuring Medicine Prices, Availability, Affordability and Price Components Geneva: World Health Organization 2008
26. Access to artesunate-amodiaquine, quinine and other antimalarials: policy and markets in Burundi. Amuasi HJ, Diap G, Blay-Nguah S, Boakye I, Karikari PE, Dismas B, Karenzo J, Nsabiyumva L, Louie SK, Kiechel J, Malar J 2011 10 34
27. Provider knowledge of treatment policy and dosing regimen with artemether-lumefantrine and quinine in malaria-endemic areas of western Kenya. Watsierah CA, Onyango RO, Ombaka JH, Abong'o BO, Ouma C, Malar J 2012 11 436
28. Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda. Fogg C, Bajunirwe F, Piola P, Biraro S, Checchi F, Kiguli J, Namiiro P, Musabe J, Kyomugisha A, Guthmann JP, Am J Trop Med Hyg 2004 71 525 530
29. Improving malaria home treatment by training drug retailers in rural Kenya. Marsh VM, Mutemi WM, Willetts A, Bayah K, Were S, Ross A, Marsh K, Trop Med Int Health 2004 9 451 460
30. Barriers to prompt and effective malaria treatment among the poorest population in Kenya. Chuma J, Okungu V, Molyneux C, Malar J 2010 9 144
31. AMFm Independent Evaluation Team, Independent Evaluation of Phase 1 of the Affordable Medicines Facility-malaria (AMFm), Multi-Country Independent Evaluation Report: Final Report Calverton, Maryland and London: ICF International and London School of Hygiene and Tropical Medicine 2012
32. WHO, Access to anti-malaria medicines, improving the affordability and financing of Artemisin-Based Combination Therapies (ACT) 2003 http://whqlibdoc.who.int/hq/2003/WHO-CDS-MAL-2003.1095.pdf, Data accessed: 22/07/2014